Screening for Early Evidence of Diabetes

CompletedOBSERVATIONAL
Enrollment

3,478

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Diabetes Mellitus, Type 2
Trial Locations (15)

11355

New York Hospital Queens-Lang Research Center, Flushing

15213

Diabetes and Lipid Research, University of Pittsburgh, Pittsburgh

20003

MedStar Research Institute, Washington D.C.

35802

Accelovance, Huntsville

45249

Radiant Research, Cincinnati

55435

Radiant Research, Edina

60610

Radiant Research, Chicago

61602

Accelovance, Peoria

66202

Radiant Research, Overland Park

73104

Oklahoma Diabetes Center, University of Oklahoma, Oklahoma City

78229

Radiant Research, San Antonio

87108

Lovelace Scientific Resources, Albuquerque

92108

Accelovance, San Diego

92161

Veteran's Administration Hospital, San Diego

96813

Kaiser Permanente-Center for Health Research, Honolulu

All Listed Sponsors
lead

VeraLight, Inc.

INDUSTRY

NCT00614783 - Screening for Early Evidence of Diabetes | Biotech Hunter | Biotech Hunter